Article Text
Archivist
Archivist
Peanut immunotherapy: still working after four years
Statistics from Altmetric.com
Peanut allergy probably causes more disruption and anxiety than any other, at least in the West, perhaps because of its propensity to cause anaphylaxis and its tendency to be lifelong. In April 2014, Archivist reported the successful outcome of the STOP II trial, where continued exposure to small but increasing amounts of ingested peanut protein effectively induced tolerance (doi.org/10.1136/archdischild-2014-306139). But the question remained: how long will this tolerance last?
Now a different trial of peanut tolerance induction through exposure has reported …
Footnotes
Handling editor Martin Ward Platt
Provenance and peer review Commissioned; internally peer reviewed.